Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2115046 | Cancer Letters | 2008 | 8 Pages |
Abstract
Inflammatory mediators are known to play a key role in tumorigenesis, therefore, it is a promising strategy to inhibit the inflammation for cancer prevention and/or treatment. Current study was performed to investigate the effects of chondroitin sulfate (CS) extracted from Styela clava tunic on TNF-α-induced inflammation and to elucidate the mechanism of CS on the regulation of inflammatory factors in JB6 cells. Our results showed that CS inhibited TNF-α-induced NF-κB activation and subsequent vascular cell adhesion molecule 1 and inducible nitric oxide synthase expressions by blocking Akt signals in JB6 cells. Our results suggest that CS may be developed as an effective anti-inflammatory agent in the future.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Cheng-Xiong Xu, Hua Jin, Youn-Sun Chung, Ji-Young Shin, Min-Ah Woo, Kee-Ho Lee, Grace N. Palmos, Byeong-Dae Choi, Myung-Haing Cho,